TRENTON – A bill sponsored by state Sen. Joseph F. Vitale to allow pharmacies in New Jersey to sell hypodermic syringes and needles without a prescription was approved by the Senate Thursday by a vote of 28-12.
“While New Jersey needs to do more to help state residents suffering from substance abuse fight their addiction, restricting access to sterile needles only succeeds in driving New Jersey’s illegal drug trade further underground, and leads to dangerous health practices, such as sharing needles,” said Vitale (D-Middlesex.) “Through this legislation, we’re not seeking to condone drug use or create a gateway to legalize otherwise illegal drugs. We’re trying to advance sound health policy which would reduce the spread of blood-borne diseases such as HIV/AIDS and hepatitis C, and address a significant public health epidemic in the Garden State.”
The bill, S-958, would permit licensed pharmacies to sell hypodermic needles and syringes, as well as other instruments adapted for the administration of drugs by injection, to individuals without a prescription in the Garden State. Under the bill, a person would have to be over 18 years old to purchase sterile needles in a pharmacy, and would be limited to 10 or fewer needles per purchase.
The supply of needles would be kept behind the sales counter, and pharmacists would, at the time of sale, provide people with information printed in English and Spanish concerning the safe disposal of needles, including local disposal locations or a telephone to call for that information, and information concerning substance abuse treatment, including a telephone number to all for assistance in obtaining treatment.
The bill would also amend current law so that individuals would be allowed to possess a hypodermic syringe or a needle without a prescription. The senators noted that the bill would also make it easier for individuals with diabetes to obtain syringes – currently, people with diabetes need a prescription to obtain syringes at the pharmacy.
“Not only does this bill have the potential to save lives and slow the spread of blood-borne diseases in New Jersey, but it would also reduce public health costs as well,” said Vitale. “We pay an enormous societal cost to provide access to health care for individuals infected by HIV/AIDS or other diseases who were first exposed through intravenous drug use. It’s time to adopt smarter health care policies regarding substance abuse treatment, and that means providing access to addiction treatment as well as clean needles to slow the spread of blood-borne infections.”
The bill now heads to the Assembly for consideration.
Connect with NJTODAY.NET
Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!